Target intelligence / Profile preview

Dystrophin exon 51 pre-messenger RNA (DMD exon 51 pre-mRNA) (DMD exon 51 pre-mRNA)

Target
DMD exon 51 pre-mRNA
Molecular classification
Other, Pre-messenger RNA
01

Overview

Dystrophin exon 51 pre-messenger RNA is a specific segment of the primary transcript of the DMD gene, which encodes the essential muscle protein dystrophin (UniProt P11532). In approximately 13% of patients with Duchenne muscular dystrophy (DMD), mutations disrupt the open reading frame, preventing the production of functional dystrophin and leading to severe, progressive muscle wasting (NIH, 2023). This pre-mRNA sequence serves as a therapeutic target for antisense oligonucleotides (ASOs) designed to induce "exon skipping." By binding to specific exonic splicing enhancer (ESE) sequences within exon 51, these drugs cause the cellular splicing machinery to bypass this exon during processing (FDA, 2016). This intervention restores the reading frame, allowing for the production of an internally truncated but partially functional dystrophin protein, effectively converting a severe DMD phenotype into a milder Becker-like muscular dystrophy phenotype (PubMed: 27638959).

Other names
DMD exon 51Dystrophin pre-mRNA exon 51Dystrophin (DMD) gene exon 51
02

Mechanism of action

Antisense oligonucleotide-mediated exon skipping to restore the mRNA reading frame.

03

Biological functions

RNA splicingProtein synthesis template
04

Disease associations

OtherMuscular dystrophy
05

Safety considerations

Infusion-related reactionsPotential renal toxicity (ASO class effect)Hypersensitivity reactionsLow efficiency of dystrophin restoration
06

Interacting drugs

Eteplirsen

3 more in the full profile.

07

Biomarkers

Dystrophin protein expression (Western blot/Immunofluorescence)Exon 51 skipping efficiency (RT-PCR)Serum creatine kinase (CK) levels6-minute walk test (6MWT)North Star Ambulatory Assessment (NSAA)

Beyond the preview

Go deeper on Dystrophin exon 51 pre-messenger RNA (DMD exon 51 pre-mRNA) (DMD exon 51 pre-mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dystrophin exon 51 pre-messenger RNA (DMD exon 51 pre-mRNA) (DMD exon 51 pre-mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call